exenatide glp 1 GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Ozempic-Like Drug Failed to Treat

Description

Critics have emphasized there is no replacement to a healthy diet and regular exercise, and that the risk of addiction, dependency or misuse associated with weight loss drugs should not be ignored

While various studies have examined the effects of GLP-1 agonists in obesity, two notable phase 3 trials are worth highlighting in this context

In her practice, Dushay has seen some patients develop or exacerbate eating disorders while taking the medications

"This consensus-based guidance highlights the critical role of nutrition in supporting patients on GLP-1 therapy, with clear recommendations for health care providers to optimize outcomes, reduce risks, and fill urgent gaps in care through practical, evidence-informed nutrition strategies. While certain considerationssuch as GI tolerance and micronutrient balanceare important for clinicians to address, the advisory emphasizes that a proactive lifestyle-based approach can mitigate risks and optimize outcomes